FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2754429523> ?p ?o ?g. }

• W2754429523 endingPage "5798" @default.
• W2754429523 startingPage "5794" @default.
• W2754429523 abstract "We previously developed and characterized an adenoviral-based prostate cancer vaccine for simultaneous targeting of prostate-specific antigen (PSA) and prostate stem cell antigen (PSCA). We also demonstrated that immunization of mice with the bivalent vaccine (Ad5-PSA+PSCA) inhibited the growth of established prostate tumors. However, there are multiple challenges hindering the success of immunological therapies in the clinic. One of the prime concerns has been to overcome the immunological tolerance and maintenance of long-term effector T cells. In this study, we further characterized the use of the bivalent vaccine (Ad5-PSA+PSCA) in a transgenic mouse model expressing human PSA in the mouse prostate. We demonstrated the expression of PSA analyzed at the mRNA level (by RT-PCR) and protein level (by immunohistochemistry) in the prostate lobes harvested from the PSA-transgenic (PSA-Tg) mice. We established that the administration of the bivalent vaccine in surgifoam to the PSA-Tg mice induces strong PSA-specific effector CD8+ T cells as measured by IFN-γ secretion and in vitro cytotoxic T-cell assay. Furthermore, the use of surgifoam with Ad5-PSA+PSCA vaccine allows multiple boosting vaccinations with a significant increase in antigen-specific CD8+ T cells. These observations suggest that the formulation of the bivalent prostate cancer vaccine (Ad5-PSA+PSCA) with surgifoam bypasses the neutralizing antibody response, thus allowing multiple boosting. This formulation is also helpful for inducing an antigen-specific immune response in the presence of self-antigen, and maintains long-term effector CD8+ T cells." @default.
• W2754429523 created "2017-09-25" @default.
• W2754429523 creator A5086713976 @default.
• W2754429523 date "2017-10-01" @default.
• W2754429523 modified "2023-09-25" @default.
• W2754429523 title "Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice" @default.
• W2754429523 cites W1584584037 @default.
• W2754429523 cites W1794190890 @default.
• W2754429523 cites W1969004313 @default.
• W2754429523 cites W1970133494 @default.
• W2754429523 cites W1972258033 @default.
• W2754429523 cites W1972950962 @default.
• W2754429523 cites W1979811833 @default.
• W2754429523 cites W1983918344 @default.
• W2754429523 cites W1984183779 @default.
• W2754429523 cites W2007335266 @default.
• W2754429523 cites W2012815184 @default.
• W2754429523 cites W2018236556 @default.
• W2754429523 cites W2020839567 @default.
• W2754429523 cites W2073778314 @default.
• W2754429523 cites W2087595240 @default.
• W2754429523 cites W2088138465 @default.
• W2754429523 cites W2092370856 @default.
• W2754429523 cites W2098773934 @default.
• W2754429523 cites W2099003743 @default.
• W2754429523 cites W2103959341 @default.
• W2754429523 cites W2109865134 @default.
• W2754429523 cites W2133075384 @default.
• W2754429523 cites W2152105813 @default.
• W2754429523 cites W2155846302 @default.
• W2754429523 cites W2162854722 @default.
• W2754429523 cites W2185447980 @default.
• W2754429523 cites W2299187660 @default.
• W2754429523 cites W2463867199 @default.
• W2754429523 cites W2522602316 @default.
• W2754429523 cites W2565687755 @default.
• W2754429523 cites W2570618306 @default.
• W2754429523 doi "https://doi.org/10.1016/j.vaccine.2017.09.037" @default.
• W2754429523 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5617798" @default.
• W2754429523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28939158" @default.
• W2754429523 hasPublicationYear "2017" @default.
• W2754429523 type Work @default.
• W2754429523 sameAs 2754429523 @default.
• W2754429523 citedByCount "7" @default.
• W2754429523 countsByYear W27544295232018 @default.
• W2754429523 countsByYear W27544295232020 @default.
• W2754429523 countsByYear W27544295232022 @default.
• W2754429523 countsByYear W27544295232023 @default.
• W2754429523 crossrefType "journal-article" @default.
• W2754429523 hasAuthorship W2754429523A5086713976 @default.
• W2754429523 hasBestOaLocation W27544295231 @default.
• W2754429523 hasConcept C121608353 @default.
• W2754429523 hasConcept C126322002 @default.
• W2754429523 hasConcept C147483822 @default.
• W2754429523 hasConcept C154317977 @default.
• W2754429523 hasConcept C167672396 @default.
• W2754429523 hasConcept C202751555 @default.
• W2754429523 hasConcept C203014093 @default.
• W2754429523 hasConcept C2776235491 @default.
• W2754429523 hasConcept C2780192828 @default.
• W2754429523 hasConcept C2781406297 @default.
• W2754429523 hasConcept C502942594 @default.
• W2754429523 hasConcept C51785407 @default.
• W2754429523 hasConcept C55493867 @default.
• W2754429523 hasConcept C71924100 @default.
• W2754429523 hasConcept C86803240 @default.
• W2754429523 hasConcept C8891405 @default.
• W2754429523 hasConceptScore W2754429523C121608353 @default.
• W2754429523 hasConceptScore W2754429523C126322002 @default.
• W2754429523 hasConceptScore W2754429523C147483822 @default.
• W2754429523 hasConceptScore W2754429523C154317977 @default.
• W2754429523 hasConceptScore W2754429523C167672396 @default.
• W2754429523 hasConceptScore W2754429523C202751555 @default.
• W2754429523 hasConceptScore W2754429523C203014093 @default.
• W2754429523 hasConceptScore W2754429523C2776235491 @default.
• W2754429523 hasConceptScore W2754429523C2780192828 @default.
• W2754429523 hasConceptScore W2754429523C2781406297 @default.
• W2754429523 hasConceptScore W2754429523C502942594 @default.
• W2754429523 hasConceptScore W2754429523C51785407 @default.
• W2754429523 hasConceptScore W2754429523C55493867 @default.
• W2754429523 hasConceptScore W2754429523C71924100 @default.
• W2754429523 hasConceptScore W2754429523C86803240 @default.
• W2754429523 hasConceptScore W2754429523C8891405 @default.
• W2754429523 hasIssue "43" @default.
• W2754429523 hasLocation W27544295231 @default.
• W2754429523 hasLocation W27544295232 @default.
• W2754429523 hasLocation W27544295233 @default.
• W2754429523 hasLocation W27544295234 @default.
• W2754429523 hasOpenAccess W2754429523 @default.
• W2754429523 hasPrimaryLocation W27544295231 @default.
• W2754429523 hasRelatedWork W1497253641 @default.
• W2754429523 hasRelatedWork W2001055320 @default.
• W2754429523 hasRelatedWork W2008949385 @default.
• W2754429523 hasRelatedWork W2042911820 @default.
• W2754429523 hasRelatedWork W2147112642 @default.
• W2754429523 hasRelatedWork W2147707434 @default.
• W2754429523 hasRelatedWork W2167570058 @default.
• W2754429523 hasRelatedWork W2220102944 @default.

• next